GB201520191D0 - T-cell receptor and uses thereof - Google Patents

T-cell receptor and uses thereof

Info

Publication number
GB201520191D0
GB201520191D0 GBGB1520191.6A GB201520191A GB201520191D0 GB 201520191 D0 GB201520191 D0 GB 201520191D0 GB 201520191 A GB201520191 A GB 201520191A GB 201520191 D0 GB201520191 D0 GB 201520191D0
Authority
GB
United Kingdom
Prior art keywords
cell receptor
receptor
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1520191.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GBGB1520191.6A priority Critical patent/GB201520191D0/en
Publication of GB201520191D0 publication Critical patent/GB201520191D0/en
Priority to MYPI2018701841A priority patent/MY193807A/en
Priority to CN201680079010.6A priority patent/CN108602875B/en
Priority to SG11201803942QA priority patent/SG11201803942QA/en
Priority to PCT/GB2016/053566 priority patent/WO2017085471A1/en
Priority to HK19101359.2A priority patent/HK1258886A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB1520191.6A 2015-11-16 2015-11-16 T-cell receptor and uses thereof Ceased GB201520191D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1520191.6A GB201520191D0 (en) 2015-11-16 2015-11-16 T-cell receptor and uses thereof
MYPI2018701841A MY193807A (en) 2015-11-16 2016-11-15 T-cell receptor and uses thereof
CN201680079010.6A CN108602875B (en) 2015-11-16 2016-11-15 T cell receptor and uses thereof
SG11201803942QA SG11201803942QA (en) 2015-11-16 2016-11-15 T-cell receptor and uses thereof
PCT/GB2016/053566 WO2017085471A1 (en) 2015-11-16 2016-11-15 T-cell receptor and uses thereof
HK19101359.2A HK1258886A1 (en) 2015-11-16 2019-01-25 T-cell receptor and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1520191.6A GB201520191D0 (en) 2015-11-16 2015-11-16 T-cell receptor and uses thereof

Publications (1)

Publication Number Publication Date
GB201520191D0 true GB201520191D0 (en) 2015-12-30

Family

ID=55132860

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1520191.6A Ceased GB201520191D0 (en) 2015-11-16 2015-11-16 T-cell receptor and uses thereof

Country Status (6)

Country Link
CN (1) CN108602875B (en)
GB (1) GB201520191D0 (en)
HK (1) HK1258886A1 (en)
MY (1) MY193807A (en)
SG (1) SG11201803942QA (en)
WO (1) WO2017085471A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220056101A1 (en) * 2018-11-27 2022-02-24 Duke University Anti-lmp2 tcr-t cell therapy for the treatment of ebv-associated cancers
CN113423724B (en) * 2018-12-27 2023-11-24 深圳华大生命科学研究院 EBV epitope high affinity T cell receptor
CN111848781A (en) * 2019-04-25 2020-10-30 天津亨佳生物科技发展有限公司 Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof
CN113621070A (en) 2020-05-06 2021-11-09 华夏英泰（北京）生物技术有限公司 T cell antigen receptor, polymer compound thereof, preparation method and application thereof
CN112940108B (en) * 2021-03-19 2022-10-14 河南省肿瘤医院 T cell receptor for identifying EBV antigen and application of T cell receptor
WO2023092452A1 (en) * 2021-11-26 2023-06-01 上海吉倍生物技术有限公司 T cell receptor for identifying ebv lmp2 antigen and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361539A (en) 1980-05-05 1982-11-30 Instrumentation Laboratory Inc. Analysis system
US6750325B1 (en) 1989-12-21 2004-06-15 Celltech R&D Limited CD3 specific recombinant antibody
US5968509A (en) 1990-10-05 1999-10-19 Btp International Limited Antibodies with binding affinity for the CD3 antigen
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
GB9206422D0 (en) 1992-03-24 1992-05-06 Bolt Sarah L Antibody preparation
US8784821B1 (en) 2003-05-31 2014-07-22 Amgen Research (Munich) Gmbh Human-anti-human cd3 binding molecules
CA2571957A1 (en) 2004-07-01 2006-01-12 Waratah Pharmaceuticals, Inc. Methods and compositions using cd3 agonists
JP5292550B2 (en) * 2007-03-23 2013-09-18 静岡県 T cell receptor β chain gene and α chain gene
CN101182531B (en) * 2007-11-09 2010-06-02 暨南大学 Recombination plasmid related with EB virus specificity TCR gene and method for constructing anti-EBV specific CTL
GB0917090D0 (en) * 2009-09-29 2009-11-11 Ucl Biomedica Plc T-cell receptor
CN110951690A (en) * 2010-09-20 2020-04-03 生物技术细胞和基因治疗公司 Antigen-specific T cell receptors and T cell epitopes
GB201314404D0 (en) * 2013-08-12 2013-09-25 Immunocore Ltd T Cell Receptors

Also Published As

Publication number Publication date
SG11201803942QA (en) 2018-06-28
CN108602875B (en) 2022-08-12
WO2017085471A1 (en) 2017-05-26
HK1258886A1 (en) 2019-11-22
MY193807A (en) 2022-10-27
CN108602875A (en) 2018-09-28

Similar Documents

Publication Publication Date Title
HK1257751A1 (en) Farnesoid x receptor agonists and uses thereof
IL258248A (en) Affinity-oligonucleotide conjugates and uses thereof
HK1247199A1 (en) Estrogen receptor modulators and uses thereof
GB201514875D0 (en) Receptor
HK1231471A1 (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof 6-- 6--2-
HK1252163A1 (en) Receptor
HK1253695A1 (en) T-cell receptor specific antibodies
IL274025A (en) Novel t-cell receptor
HK1252026A1 (en) Pharmaceutical combination and uses thereof
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
HK1258886A1 (en) T-cell receptor and uses thereof
GB201702617D0 (en) Receptor
HK1247122A1 (en) Combinations and uses thereof
IL254241A0 (en) Etv2 and uses thereof
PL3347376T3 (en) Novel igfr-like receptor and uses thereof
HK1253294A1 (en) Opioid receptor modulators and use thereof
GB201719169D0 (en) Novel T-cell receptor and ligand
IL258042A (en) Tcr and uses thereof
GB201701887D0 (en) Receptor
GB201700926D0 (en) Receptor
GB2545167B (en) Cloches and use thereof
GB201513796D0 (en) Materials and Devices
HUP1500514A2 (en) New ppv1 strain and uses thereof
GB201417498D0 (en) T-Cell monotypia and clonality
GB201504923D0 (en) Carrying device

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)